United States OTC Drug Market Research Report Forecast 2017-2021

June 2017 | 114 pages | ID: UC4813F44A9EN
S&P Consulting

Abstracts

The United States OTC Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the OTC Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This OTC Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica

United States OTC Drug Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States OTC Drug Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 OTC DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of OTC Drug
1.2 OTC Drug Market Segmentation by Type
  1.2.1 United States Production Market Share of OTC Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 OTC Drug Market Segmentation by Application
  1.3.1 OTC Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of OTC Drug (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON OTC DRUG INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES OTC DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 United States OTC Drug Production and Share by Manufacturers (2015 and 2016)
3.2 United States OTC Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States OTC Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers OTC Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 OTC Drug Market Competitive Situation and Trends
  3.5.1 OTC Drug Market Concentration Rate
  3.5.2 OTC Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES OTC DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States OTC Drug Production and Market Share by Type (2012-2017)
4.2 United States OTC Drug Revenue and Market Share by Type (2012-2017)
4.3 United States OTC Drug Price by Type (2012-2017)
4.4 United States OTC Drug Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES OTC DRUG MARKET ANALYSIS BY APPLICATION

5.1 United States OTC Drug Consumption and Market Share by Application (2012-2017)
5.2 United States OTC Drug Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES OTC DRUG MANUFACTURERS ANALYSIS

6.1 Bayer HealthCare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 GlaxoSmithKline (GSK)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Johnson&Johnson
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 AstraZeneca
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 BioGaia
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Bristol Myers Squibb
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Bukwang Pharmaceutica
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 OTC DRUG MANUFACTURING COST ANALYSIS

7.1 OTC Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of OTC Drug

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 OTC Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES OTC DRUG MARKET FORECAST (2017-2021)

11.1 United States OTC Drug Production, Revenue Forecast (2017-2021)
11.2 United States OTC Drug Production, Consumption Forecast by Regions (2017-2021)
11.3 United States OTC Drug Production Forecast by Type (2017-2021)
11.4 United States OTC Drug Consumption Forecast by Application (2017-2021)
11.5 OTC Drug Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of OTC Drug
Table Classification of OTC Drug
Figure United States Sales Market Share of OTC Drug by Type in 2015
Table Application of OTC Drug
Figure United States Sales Market Share of OTC Drug by Application in 2015
Figure United States OTC Drug Sales and Growth Rate (2011-2021)
Figure United States OTC Drug Revenue and Growth Rate (2011-2021)
Table United States OTC Drug Sales of Key Manufacturers (2015 and 2016)
Table United States OTC Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 OTC Drug Sales Share by Manufacturers
Figure 2016 OTC Drug Sales Share by Manufacturers
Table United States OTC Drug Revenue by Manufacturers (2015 and 2016)
Table United States OTC Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States OTC Drug Revenue Share by Manufacturers
Table 2016 United States OTC Drug Revenue Share by Manufacturers
Table United States Market OTC Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market OTC Drug Average Price of Key Manufacturers in 2015
Figure OTC Drug Market Share of Top 3 Manufacturers
Figure OTC Drug Market Share of Top 5 Manufacturers
Table United States OTC Drug Sales by Type (2012-2017)
Table United States OTC Drug Sales Share by Type (2012-2017)
Figure United States OTC Drug Sales Market Share by Type in 2015
Table United States OTC Drug Revenue and Market Share by Type (2012-2017)
Table United States OTC Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of OTC Drug by Type (2012-2017)
Table United States OTC Drug Price by Type (2012-2017)
Figure United States OTC Drug Sales Growth Rate by Type (2012-2017)
Table United States OTC Drug Sales by Application (2012-2017)
Table United States OTC Drug Sales Market Share by Application (2012-2017)
Figure United States OTC Drug Sales Market Share by Application in 2015
Table United States OTC Drug Sales Growth Rate by Application (2012-2017)
Figure United States OTC Drug Sales Growth Rate by Application (2012-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer HealthCare OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer HealthCare OTC Drug Market Share (2012-2017)
Table GlaxoSmithKline (GSK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline (GSK) OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline (GSK) OTC Drug Market Share (2012-2017)
Table Johnson&Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson&Johnson OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson&Johnson OTC Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer OTC Drug Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi OTC Drug Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca OTC Drug Market Share (2012-2017)
Table BioGaia Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BioGaia OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table BioGaia OTC Drug Market Share (2012-2017)
Table Bristol Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol Myers Squibb OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol Myers Squibb OTC Drug Market Share (2012-2017)
Table Bukwang Pharmaceutica Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bukwang Pharmaceutica OTC Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Bukwang Pharmaceutica OTC Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Manufacturers in 2015
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure United States OTC Drug Production and Growth Rate Forecast (2017-2021)
Figure United States OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Table United States OTC Drug Production Forecast by Type (2017-2021)
Table United States OTC Drug Consumption Forecast by Application (2017-2021)